Search:

Home Index Back issues Contact

 

Volume 4, Number 3

 

Managing pregnancy and aPL

Beverley J Hunt MD FRCP FRCPath Consultant Haematologist; Cathy Nelson-Piercy MA FRCP Consultant Obstetric Physician; Susan Bewley MRCOG MD MA Consultant Obstetrician; Munther Khamashta MD PhD Consultant Rheumatologist, The Lupus Pregnancy Clinic, Guy’s & St Thomas’ Hospital Trust, London

The article on antiphospholipid syndrome (APS) in Thrombus 4.2 covered clinical and laboratory diagnoses and management of thrombotic disease. This article highlights the practical issues of managing APS during pregnancy.

 

Infection as a cause of CHD

Amarjit Sethi BSc MRCP Cardiology Research Fellow, The William Harvey Research Institute, London; John C Hogan BSc MD FRCP Consultant Cardiologist; Sandeep Gupta MD MRCP Consultant Cardiologist, Whipps Cross and St Bartholomew’s Hospitals, London

Despite the recent growth in preventive strategies and cardiovascular interventions, coronary heart disease (CHD) today remains a major cause of morbidity and mortality in industrialised countries and is steadily increasing in developing countries.1 Traditional risk factors such as hypercholesterolaemia, smoking, hypertension and diabetes mellitus do not fully explain the extent or severity of disease in many patients. There has been increasing interest in the role of novel risk factors and, in particular, an infectious aetiology to atherosclerosis.

 

Centralising thrombophilia patient information

Steve Davidson BSc (Hons) RN DipN Haemostasis & Thrombosis Clinical Nurse, Queen’s Medical Centre, Nottingham

Recently, a computer system has been developed for the Windows® 95, 98 and NT environments to promote the co-ordination of thrombophilia-related information. Its major aim is to act as an assistant during patient consultations and to aid the total care management of thrombophilia patients.

 

Laboratory tests: why do we need them?

Peter Rose, Editor

Requesting tests in medicine, without considering the consequences should the result come back abnormal, is an all too frequent mistake.

 

A review of primary care anticoagulation management

David Fitzmaurice MD Senior Lecturer; Ellen Murray SRN MHS Research Fellow, Department of General Practice, The Medical School, The University of Birmingham; Jim Murray FRCP FRCPath Consultant Haematologist, University Hospital NHS Trust Birmingham

Long-term oral anticoagulant care has traditionally involved repeated attendance at a hospital anticoagulant clinic because of the need for laboratory testing, expert interpretation of the result and adjustment of warfarin dose. The existing services are now under
even greater strain due to the increasing number of patients requiring long-term anticoagulation, particularly stroke prophylaxis in atrial fibrillation.1

 

 


The data, opinions and statements appearing in the articles herein are those of the contributor(s) concerned; they are not necessarily endorsed by the sponsors, publisher, Editor or Editorial Board. Accordingly the sponsors, publisher, Editor and Editorial Board and their respective employees, officers and agents accept no liability for the consequences of any such inaccurate or misleading data, opinion or statement.
Copyright (©) 2010 Hayward Group Ltd. The title Thrombus is the property of Hayward Group Ltd and, together with the content, is bound by copyright. The information contained on the site may not be reproduced, distributed or published, in whole or in part, in any form without the permission of the publishers. All correspondence should be addressed to: admin@hayward.co.uk